Weekly signal · AXSM · Healthcare

Axsome Therapeutics Inc (AXSM) finishes week 9.8% higher in active trend

The CNS-therapy developer’s twelve-week return is now 62.6%, putting the move in a broader biotech rebound rather than a single-week move.

Axsome Therapeutics Inc
Latest255.17 USD
1W move9.8%
Volume1.0x
TrendActive
Weekly chart for Axsome Therapeutics showing share price and volume over 52 weeks.

Market update

What happened

Axsome Therapeutics Inc (AXSM) closed the latest week at $255.17, extending its four-week advance to 12.1% as of June 12. The Healthcare stock remains a large-cap biotechnology mover with a market value of about $12.0 billion.

In the weekly price path over 52 weeks, the trend signal is active and volume was near normal at 3.44 million shares, or 0.99x the 13-week average. Market Dynamics at 1.15 adds confirmation, but Relative Strength at 41.2 leaves the evidence mixed rather than uniformly strong.

Continue your research

Explore AXSM across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

AXSM coverage

Evidence context